ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
96 936,87
-0,28%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Dyadic International Inc (DYAI) Cours

Dyadic International Inc

Dyadic International Inc (DYAI)

NASDAQ
1,75
-0,155
(-8,14%)
Fermé 22 Décembre 10:00PM
Retardé de 15 minutes
1,89
0,14
(8,00%)
Après les heures de négociation: 1:59AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
1,89
Prix Achat
1,80
Prix Vente
2,01
Volume échangé
266 197
1,72 Fourchette du Jour 2,0502
0,9257 Plage de 52 semaines 2,67
Cap du marché
55,924M
Clôture Veille
1,905
Ouverture
1,98
Dernière Transaction
100
@
1.89
(formt)
Dernière heure de transaction
Volume financier
US$ 506 563
VWAP
1,903
Volume moyen (3 m)
62 917
Actions en circulation
29 589 371
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-7,49
Bénéfice par action (BPA)
-0,23
Chiffre d'affairess
2,9M
Bénéfice net
-6,8M

À propos de Dyadic International Inc

Dyadic International Inc is a biotechnology company engaged in the discovery, development, manufacturing and selling of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries. Dyadic International Inc is a biotechnology company engaged in the discovery, development, manufacturing and selling of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biogenetic (human)
Site Web
www.dyadic.com
Siège social
Wilmington, Delaware, USA
Fondé
1979
Dyadic International Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker DYAI. Le dernier cours de clôture d'Dyadic était de US$1,91. Au cours de la dernière année, les actions de Dyadic ont été négociées dans une fourchette de prix de US$ 0,9257 à US$ 2,67.

Dyadic compte actuellement 29 589 371 actions en circulation. La capitalisation boursière d'Dyadic est de US$56,37 million. Dyadic a un ratio cours/bénéfice (ratio PE) de -7.49.

DYAI Dernières nouvelles

Plus de nouvelles

Form 144 - Report of proposed sale of securities

20 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

26 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 Novembre 2024
Edgar (US Regulatory)

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the...

21 Novembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

12 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Novembre 2024
Edgar (US Regulatory)

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue...

12 Novembre 2024
GlobeNewswire Inc.

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...

04 Novembre 2024
GlobeNewswire Inc.

Dyadic Expands Global Presence with Participation in Key Industry Events

JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient...

09 Octobre 2024
GlobeNewswire Inc.

Form 8-K - Current report

08 Octobre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.2817.39130434781.612.21.36012495731.91000842CS
40.1911.17647058821.72.21.36011096911.87774411CS
120.7870.27027027031.112.20.9257629171.62369044CS
260.179.883720930231.722.20.9257500691.53884264CS
520.3421.9354838711.552.670.9257533681.73190832CS
156-2.5801-57.71906668754.47014.980.9257454392.1757119CS
260-3.28-63.44294003875.1711.640.92573125884.86352773CS

DYAI - Frequently Asked Questions (FAQ)

What is the current Dyadic share price?
The current share price of Dyadic is US$ 1,89
How many Dyadic shares are in issue?
Dyadic has 29 589 371 shares in issue
What is the market cap of Dyadic?
The market capitalisation of Dyadic is USD 56,37M
What is the 1 year trading range for Dyadic share price?
Dyadic has traded in the range of US$ 0,9257 to US$ 2,67 during the past year
What is the PE ratio of Dyadic?
The price to earnings ratio of Dyadic is -7,49
What is the cash to sales ratio of Dyadic?
The cash to sales ratio of Dyadic is 17,55
What is the reporting currency for Dyadic?
Dyadic reports financial results in USD
What is the latest annual turnover for Dyadic?
The latest annual turnover of Dyadic is USD 2,9M
What is the latest annual profit for Dyadic?
The latest annual profit of Dyadic is USD -6,8M
What is the registered address of Dyadic?
The registered address for Dyadic is 3411 SILVERSIDE ROAD TATNALL BUILDING, SUITE 104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Dyadic website address?
The website address for Dyadic is www.dyadic.com
Which industry sector does Dyadic operate in?
Dyadic operates in the BIOGENETIC (HUMAN) sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,5M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,63M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,84M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
8,58M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
5,96M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
DYAI
Dyadic
LSE
42PF
Int.fin. 3%46
LSE
59XL
Investec Bnk 24
NASDAQ
CEBBX
Ci Global Leaders Fund S...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés